Breaking news from across the pharma sector
The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, today entered into a partnership with SRG, leaders in life science recruitment, to support the advancement of science professionals in their careers.
A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
: Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced an agreement with Debiopharm, a biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases. The agreement will support the development of Debiopharm’s USP1 inhibitor programme, Debio 0432.
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.
ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the introduction of the AugaOne™ sensor system. AugaOne is the first product in the Company’s sensor system platform, Auga™, and is tailored to accelerate downstream monoclonal antibody (mAb) process development by providing specific real-time and automated in-line data with high sensitivity, without requiring sample pretreatment.
Between 6-10th November 2023, a five-day inspection was undertaken, which concluded successfully with no critical and no major observations raised. A Good Manufacturing Practice (GMP) certificate has been granted to the site by the authority
Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today introduced its SemaCyte® Multiplexing Platform, an expansion to the existing SemaCyte Microcarrier platform to utilize optical barcoding to accelerate screening processes during in vitro drug discovery.
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been awarded a highly competitive Biomedical Catalyst grant for industry-led research and development (R&D) from Innovate UK, the UK’s innovation agency.
Developed for ultra-high precision in the micron range, SICK’s innovative and compact OD7000 displacement sensor reliably measures tiny distances in challenging applications cost-effectively. Comprising a separate controller and sensor head that are both extremely compact, the OD7000 is purpose-built to fit into the tightest machine spaces. The SICK OD7000 is a 1D laser distance sensor that measures differences in height accurately even on challenging materials.
Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its eProtein Discovery benchtop protein platform, today announced it has been selected to join the Tech Nation Future Fifty 2024 cohort, a unique program designed for the UK’s next generation of unicorn founders, recognizing the most promising late-stage technology ventures.
Data-driven laboratory and manufacturing operational connectivity pioneer Elemental Machines announced the addition of Rob Estrella as its new SVP of Global Sales. . Estrella joined Elemental Machines to support their continued and deep commitment to serving the life sciences market and growth of enterprise-level Internet of Things (IoT) technology across laboratory and manufacturing spaces.
CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, today announced the close of its oversubscribed seed funding round. The £500k GBP investment came from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), which includes previous investors Oxford Technology Management.